Example: confidence
LUPRON DEPOT 3.75 mg (leuprolide acetate for …
LUPRON DEPOT® 3.75 mg (leuprolide acetate for depot suspension) Rx only DESCRIPTION Leuprolide acetate is a synthetic nonapeptide analog of naturally occurring gonadotropin-
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
HIGHLIGHTS OF PRESCRIBING INFORMATION • …
www.rxabbvie.comPrior to initiating DUOPA, convert patients from all other forms of levodopa to oral immediate-release carbidopa-levodopa tablets (1:4 ratio). Patients should remain on a stable dose of their
DOSAGE AND ADMINISTRATION WARNINGS AND …
www.rxabbvie.comFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE CREON® (pancrelipase) is indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatectomy, or other conditions.
HIGHLIGHTS OF PRESCRIBING INFORMATION 1.In …
www.rxabbvie.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use MAVYRET safely and effectively. See full prescribing information …
HIGHLIGHTS OF PRESCRIBING INFORMATION ... - …
www.rxabbvie.comFULL PRESCRIBING INFORMATION WARNING: NOT FOR TREATMENT OF OBESITY OR FOR WEIGHT LOSS Thyroid hormones, including SYNTHROID, either alone or …
MEDICATION GUIDE - RxAbbVie
www.rxabbvie.comMEDICATION GUIDE HUMIRA® (Hu-MARE-ah) (adalimumab) injection Read the Medication Guide that comes with HUMIRA before you start taking it …
MEDICATION GUIDE - RxAbbVie
www.rxabbvie.comMEDICATION GUIDE HUMIRA® (Hu-MARE-ah) (adalimumab) injection Read the Medication Guide that comes with HUMIRA before …
HIGHLIGHTS OF PRESCRIBING INFORMATION - …
www.rxabbvie.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TECHNIVIE safely and effectively. See full …
VENCLEXTA (venetoclax tablets) for oral use or after ...
www.rxabbvie.comPatients should continue VENCLEXTA 400 mg once daily for 24 months from Cycle 1 Day 1 of rituximab. VENCLEXTA as Monotherapy The recommended dose of VENCLEXTA is 400 mg once daily after the patient has completed
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.rxabbvie.comFULL PRESCRIBING INFORMATION WARNING: SECONDARY EXPOSURE TO TESTOSTERONE • Virilization has been reported in children who were secondarily exposed to testosterone gel [see Warnings and Precautions (5.2) and Adverse Reactions (6.2)]. • Children should avoid contact with unwashed or unclothed application sites in men using testosterone gel [see Dosage and Administration (2.2) and Warnings …
HIGHLIGHTS OF PRESCRIBING INFORMATION DOSAGE …
www.rxabbvie.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ANDROGEL 1.62% safely and effectively.
Related documents
LUPRON DEPOT -3 Month 11.25 mg (leuprolide …
www.accessdata.fda.govLUPRON DEPOT®-3 Month 11.25 mg (leuprolide acetate for depot suspension) 3-MONTH FORMULATION . Rx only . DESCRIPTION . Leuprolide acetate is a synthetic nonapeptide analog of naturally occurring gonadotropin-releasing hormone
DRUG NAME: Leuprolide - BC Cancer
www.bccancer.bc.caLeuprolide DRUG NAME: Leuprolide SYNONYM: Leuprorelin acetate1 COMMON TRADE NAME(S): ELIGARD®, LUPRON®, LUPRON DEPOT® CLASSIFICATION: hormonal agent Special pediatric considerations are noted when applicable, otherwise adult provisions apply.
DRUGS AND COSMETICS (2 ND AMENDMENT) …
rajswasthya.nic.in304. megestrol acetate 305. meglumine iocarmate 306. melagenina 307. melitracen hydrochloride 308. meloxicam 309. mephenesin, its esters 310. mephentermine
INJECTABLE MEDICATIONS FEE SCHEDULE …
ahca.myflorida.compage 5 of 5 code description max qty rate comments/notes injectable medications fee schedule oncology 01/01/2018 j9354 ado-trastuzumab emtansine 1mg 400 29.00
BC CANCER HAZARDOUS DRUG LIST
www.bccancer.bc.caBC CANCER HAZARDOUS DRUG LIST (Refer to: Pharmacy Directive VI-80 Hazardous Drug List) The BC Cancer Hazardous Drug List (BC Cancer HD List) is comprised of:
DEPOT PREFILLED DUAL-CHAMBER SYRINGE (PDS) …
www.medicines.org.auLucrin Depot Prefilled Dual-Chamber Syringe (PDS) Injection Version 13 12 May 2015 Page 3 of 18 rate following the onset of steady-state levels during the third week after dosing, providing steady